Pfizer, Starboard Value
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Two former Pfizer executives published a statement saying they support the current company management as it gets pressured ...
Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
The about face comes as the board grapples with the activist’s efforts, and just days before Starboard’s Jeff Smith was ...
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Guggenheim Securities, LLC has issued a statement on behalf of former Pfizer Chief Executive Officer Ian Read and former Chief ...
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback